Egypt vs Papua New Guinea: Share of pregnant women with HIV that receive antiretroviral therapy
Egypt
27.0%
in 2024
Papua New Guinea
28.0%
in 2024
Egypt rank
79th
Papua New Guinea rank
78th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Egypt
- Papua New Guinea
How they compare
Papua New Guinea currently reports 28.0% against 27.0% in Egypt, a difference of 1.0%.
The two have swapped places 10 times across 25 shared years of data; in 2000 it was Papua New Guinea ahead.
Egypt ranks 79th and Papua New Guinea ranks 78th of 84 countries.
Across the 3 decades both report, Egypt averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Egypt | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 0.7% | 0.0% | — |
| 2010s | 9.7% | 10.9% | 1.2% | Papua New Guinea |
| 2020s | 25.2% | 20.6% | 4.6% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Egypt or Papua New Guinea?
- Papua New Guinea, at 28.0% against 27.0% in Egypt as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Egypt and Papua New Guinea?
- 1.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Egypt and Papua New Guinea?
- 25 years are reported by both, from 2000 to 2024.
- How do Egypt and Papua New Guinea rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Egypt ranks 79th and Papua New Guinea ranks 78th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.